Previous Article | Next Article ![]()
Clinical and Vaccine Immunology, February 2009, p. 260-276, Vol. 16, No. 2
1071-412X/09/$08.00+0 doi:10.1128/CVI.00355-08
Copyright © 2009, American Society for Microbiology. All Rights Reserved.
,
Ian Schiller,2
Payam Nahid,4
Philip C. Hopewell,1,4
Andrew Ramsay,5
Madhukar Pai,2 and
Suman Laal6,7,8
Francis J. Curry National Tuberculosis Center, University of California, San Francisco, California,1 Department of Epidemiology, Biostatistics & Occupational Health, McGill University, Montréal, Quebec, Canada,2 San Joaquin County Public Health Services, Stockton, California,3 Division of Pulmonary and Critical Care Medicine, San Francisco General Hospital, University of California, San Francisco, California,4 UNICEF/UNDP/World Bank/WHO Special Programme for Research and Training in Tropical Diseases, World Health Organization, Geneva, Switzerland,5 Departments of Pathology,6 Microbiology, New York University Langone Medical Center, New York, New York,7 Veterans Affairs Medical Center, New York, New York8
Received 26 September 2008/ Returned for modification 4 November 2008/ Accepted 24 November 2008
Serological antibody detection tests for tuberculosis may offer the potential to improve diagnosis. Recent meta-analyses have shown that commercially available tests have variable accuracies and a limited clinical role. We reviewed the immunodiagnostic potential of antigens evaluated in research laboratories (in-house) for the serodiagnosis of pulmonary tuberculosis and conducted a meta-analysis to evaluate the performance of comparable antigens. Selection criteria included the participation of at least 25 pulmonary tuberculosis patients and the use of purified antigens. Studies evaluating 38 kDa, MPT51, malate synthase, culture filtrate protein 10, TbF6, antigen 85B,
-crystallin, 2,3-diacyltrehalose, 2,3,6-triacyltrehalose, 2,3,6,6'-tetraacyltrehalose 2'-sulfate, cord factor, and TbF6 plus DPEP (multiple antigen) were included in the meta-analysis. The results demonstrated that (i) in sputum smear-positive patients, sensitivities significantly
50% were provided for recombinant malate synthase (73%; 95% confidence interval [CI], 58 to 85) and TbF6 plus DPEP (75%; 95% CI, 50 to 91); (ii) protein antigens achieved high specificities; (iii) among the lipid antigens, cord factor had the best overall performance (sensitivity, 69% [95% CI, 28 to 94]; specificity, 91% [95% CI, 78 to 97]); (iv) compared with the sensitivities achieved with single antigens (median sensitivity, 53%; range, 2% to 100%), multiple antigens yielded higher sensitivities (median sensitivity, 76%; range, 16% to 96%); (v) in human immunodeficiency virus (HIV)-infected patients who are sputum smear positive, antibodies to several single and multiple antigens were detected; and (vi) data on seroreactivity to antigens in sputum smear-negative or pediatric patients were insufficient. Potential candidate antigens for an antibody detection test for pulmonary tuberculosis in HIV-infected and -uninfected patients have been identified, although no antigen achieves sufficient sensitivity to replace sputum smear microscopy. Combinations of select antigens provide higher sensitivities than single antigens. The use of a case-control design with healthy controls for the majority of studies was a limitation of the review. Efforts are needed to improve the methodological quality of tuberculosis diagnostic studies.
Published ahead of print on 3 December 2008.
Supplemental material for this article may be found at http://cvi.asm.org/.
Present address: California Department of Public Health, Sacramento, CA.
This article has been cited by other articles:
Copyright © 2009 by the American Society for Microbiology. For an alternate route to Journals.ASM.org, visit: http://intl-journals.asm.org | More Info»